title: Bupropion for smoking cessation: a review.
abstract: Smoking tobacco is the leading cause of preventable death. Bupropion is the only antidepressant recommended as first-line pharmacotherapy for smoking cessation. Bupropion is as effective as nicotine replacement therapy and can be used in diverse populations.
authors.affiliation: Division of General Internal Medicine and Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, CA, USA.
authors.forename: Elisa K
authors.initials: EK
authors.lastname: Tong
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Carmody
authors.forename: Joel A
authors.initials: JA
authors.lastname: Simon
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016642:Bupropion / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use*; D055502:Secondary Prevention; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation / Q000208:ethnology / Q000379:methods*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion; D009538:Nicotine